sf-837 and erythromycin-stearate

sf-837 has been researched along with erythromycin-stearate* in 2 studies

Other Studies

2 other study(ies) available for sf-837 and erythromycin-stearate

ArticleYear
Comparative study on effects of 14- and 16-membered macrolides on gastrointestinal motility in unanaesthetized dogs.
    Drugs under experimental and clinical research, 1988, Volume: 14, Issue:5

    Comparative studies on the effects of 14-membered and 16-membered macrolides on gastrointestinal motility were conducted in unanaesthetized dogs. Midecamycin acetate, a new 16-membered macrolide, and leucomycin, another 16-membered macrolide, did not disturb the gastrointestinal motility and no dogs showed any adverse effects. In contrast, erythromycin stearate, erythromycin ethylsuccinate and triacetyloleandomycin, 14-membered macrolides, caused adverse effects such as strong contractile motility, nausea, vomiting and diarrhoea. The adverse effects of macrolides on the gastrointestinal tract are related to their chemical structure.

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Dogs; Erythromycin; Female; Gastrointestinal Motility; Injections, Intravenous; Leucomycins; Structure-Activity Relationship; Troleandomycin

1988
[Correlation between in vitro dissolution characteristics of macrolide antibiotic tablets and bioavailability in man].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1987, Volume: 107, Issue:9

    Topics: Adult; Biological Availability; Drug Stability; Erythromycin; Gastric Acid; Humans; Leucomycins; Middle Aged; Miocamycin; Solubility; Tablets

1987